Related Experiment Video
Updated: May 7, 2026

05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
A simplified method to quantify dysregulated tyrosine transport in schizophrenia
Rodolfo Bongiovanni1, Sherry Leonard, George E Jaskiw
1Psychiatry Service, Louis Stokes Cleveland DVAMC, Cleveland, OH 44106, United States.
Schizophrenia Research
|September 21, 2013
Summary
Schizophrenia patients show altered tyrosine transport, with lower maximal transport velocity. This can be studied without radioactive tracers and is affected by antipsychotic drugs.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Schizophrenia is linked to abnormal tyrosine transport across cell membranes.
- Current methods often rely on radiolabeled tyrosine uptake in fibroblasts.
- Investigating alternative methods and drug effects is crucial.
Purpose of the Study:
- To determine if unlabeled tyrosine can characterize tyrosine transport.
- To assess the impact of antipsychotic drugs on tyrosine uptake.
Main Methods:
- Fibroblast cultures from schizophrenia patients and controls were used.
- Tyrosine uptake was measured using unlabeled tyrosine under varying concentrations.
- Michaelis-Menten parameters and drug effects were analyzed.
Main Results:
- Tyrosine uptake was sodium-independent.
- Maximal transport velocity (Vmax) was significantly lower in schizophrenia patients.
- Antipsychotic drugs differentially affected tyrosine uptake.
Conclusions:
- Tyrosine kinetics in schizophrenia can be studied without radiolabeled tracers.
- The findings suggest complex pharmacological influences on tyrosine transport.

